...
首页> 外文期刊>Seminars in Respiratory and Critical Care Medicine >Current status of idiopathic nonspecific interstitial pneumonia
【24h】

Current status of idiopathic nonspecific interstitial pneumonia

机译:特发性非特异性间质性肺炎的现状

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pulmonary pathologists were aware of cases of idiopathic interstitial pneumonia (IIP) that morphologically did not fit Liebow's classification scheme. These cases were labeled as "cellular interstitial pneumoniao" or "chronic interstitial pneumonia not otherwise specified.o" The term nonspecific interstitial pneumonia (NSIP) was first used in relation to a pattern of lung interstitial inflammation seen in association with human immunodeficiency virus (HIV) infection. In 1994 NSIP was used to indicate a group of subacute or chronic interstitial pneumonias characterized morphologically by interstitial inflammation or fibrosis or both, with preservation of the lung architecture and the absence of typical findings for any of the other main categories of IIP (mainly usual interstitial pneumonia, desquamative interstitial pneumonia, and bronchiolitis obliterans organizing pneumonia). Although these patients presented with "nonspecifico" lung histology (categorized as cellular and fibrotic variants), and with a broad spectrum of associated clinical conditions, such as connective tissue diseases (CTDs), environmental exposure, and previous acute lung injury, they showed some peculiar clinical aspects, including favorable response to corticosteroid treatment and overall good prognosis. The clinical and radiographic profiles were better defined in the last decade. The NSIP pattern is the histological background of a subacute/chronic interstitial pneumonitis that may be observed in many conditions, including CTD, drug-induced lung disease, hypersensitivity pneumonitis, slowly healing diffuse alveolar damage (DAD), relapsing organizing pneumonia, occupational exposure, immunodeficiency (mainly HIV infection), graft versus host disease (GVHD), familial pulmonary fibrosis, immunoglobulin G4 (IgG4)-related sclerosing disease, with or without overlap features with Rosai-Dorfman disease, multicentric Castleman disease, and myelodysplastic syndrome. Rarely, NSIP is the histology recognized in patients with idiopathic interstitial pneumonitis, in whom efforts to find potential causative exposures are futile. This entity occurs mostly in middle-aged, never-smoker women, with a likely association with an autoimmune background. High-resolution computed tomographic (HRCT) scans typically demonstrate ground-glass attenuation with a bibasilar distribution, or in the fibrotic variant, ground-glass attenuation along with reticular lines and traction bronchiectasis. The prognosis is good compared with idiopathic pulmonary fibrosis (IPF), and therapeutic options include mainly corticosteroids and immunosuppressive agents. Recently a more precise definition of clinical profiles and radiographic findings of idiopathic NSIP allows consideration of less invasive diagnostic procedures (bronchoalveolar lavage, transbronchial lung biopsy). Better understanding of pathogenetic mechanisms might widen the therapeutic horizon giving a role to new therapeutic options in more severe cases.
机译:肺部病理学家意识到,特发性间质性肺炎(IIP)的形态在形态上不符合Liebow的分类方案。这些病例被标记为“细胞间质性肺炎”或“未另外指明的慢性间质性肺炎。”术语“非特异性间质性肺炎(NSIP)”首先用于与人类免疫缺陷病毒(HIV)相关的肺间质炎症的模式。 ) 感染。 1994年,NSIP被用于指示一组亚急性或慢性间质性肺炎,其形态学特征为间质性炎症或纤维化或两者兼有,并保留了肺部结构,而对于IIP的其他其他主要类别(主要是通常的间质性肺炎,脱屑性间质性肺炎和闭塞性细支气管炎组织性肺炎)。尽管这些患者表现出“非特异性”肺组织学(分类为细胞和纤维化变体),并具有广泛的相关临床状况,例如结缔组织疾病(CTD),环境暴露和先前的急性肺损伤,但他们表现出一些特殊的临床方面,包括对皮质类固醇激素治疗的良好反应以及总体预后良好。在过去的十年中,对临床和放射学特征有了更好的定义。 NSIP模式是亚急性/慢性间质性肺炎的组织学背景,可在许多情况下观察到,包括CTD,药物诱发的肺部疾病,超敏性肺炎,缓慢愈合的弥漫性肺泡损伤(DAD),复发性组织性肺炎,职业性暴露,免疫缺陷(主要是HIV感染),移植物抗宿主病(GVHD),家族性肺纤维化,免疫球蛋白G4(IgG4)相关性硬化病,有或没有与Rosai-Dorfman病,多中心Castleman病和骨髓增生异常综合症的特征。很少,NSIP是特发性间质性肺炎患者中公认的组织学,在这些患者中,寻找潜在病因暴露的努力是徒劳的。该实体多发于中年,不​​吸烟的女性,可能与自身免疫背景有关。高分辨率计算机断层扫描(HRCT)扫描通常显示毛玻璃衰减为双基底分布,或者在纤维化变体中显示毛玻璃衰减以及网状线和牵引性支气管扩张。与特发性肺纤维化(IPF)相比,预后良好,治疗选择主要包括皮质类固醇和免疫抑制剂。最近,对特发性NSIP的临床特征和影像学发现的更精确定义允许考虑采用侵入性较小的诊断程序(支气管肺泡灌洗,经支气管肺活检)。更好地了解致病机理可能会拓宽治疗范围,在更严重的情况下为新的治疗选择发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号